CyVek, Inc. is engaged in the development of a novel, platform technology for measuring analytes in biological samples. The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation. With its world-class team of engineers and scientists, CyVek plans to leverage its innovative and proprietary approach throughout the life sciences and clinical diagnostics fields.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/14/12 | $3,000,000 | |||
| 02/08/13 | $5,500,000 | Series D |
Connecticut Innovations | undisclosed |
